CN109329935A - 复方蒲公英花粉通淋膏及其制备方法 - Google Patents
复方蒲公英花粉通淋膏及其制备方法 Download PDFInfo
- Publication number
- CN109329935A CN109329935A CN201810910143.4A CN201810910143A CN109329935A CN 109329935 A CN109329935 A CN 109329935A CN 201810910143 A CN201810910143 A CN 201810910143A CN 109329935 A CN109329935 A CN 109329935A
- Authority
- CN
- China
- Prior art keywords
- weight
- dosage
- parts
- pollen
- dandelion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000245665 Taraxacum Species 0.000 title claims abstract description 118
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 title claims abstract description 117
- 150000001875 compounds Chemical class 0.000 title claims abstract description 57
- 239000006071 cream Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 229940109850 royal jelly Drugs 0.000 claims abstract description 85
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 65
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 65
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 64
- 235000012907 honey Nutrition 0.000 claims abstract description 59
- 239000002504 physiological saline solution Substances 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 22
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000013078 crystal Substances 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 238000013329 compounding Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 239000002893 slag Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 230000035479 physiological effects, processes and functions Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 14
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 37
- 208000004880 Polyuria Diseases 0.000 description 27
- 230000035619 diuresis Effects 0.000 description 27
- 230000001939 inductive effect Effects 0.000 description 21
- 239000000047 product Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 241000256844 Apis mellifera Species 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 239000012467 final product Substances 0.000 description 8
- 229960003284 iron Drugs 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 201000007227 lymph node tuberculosis Diseases 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 6
- 240000006079 Schisandra chinensis Species 0.000 description 6
- 235000008422 Schisandra chinensis Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 208000004396 mastitis Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 230000003796 beauty Effects 0.000 description 5
- 206010006451 bronchitis Diseases 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 206010010741 Conjunctivitis Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000007882 Gastritis Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 201000004484 acute conjunctivitis Diseases 0.000 description 4
- 206010001093 acute tonsillitis Diseases 0.000 description 4
- 201000001352 cholecystitis Diseases 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000019206 urinary tract infection Diseases 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000003471 anti-radiation Effects 0.000 description 3
- 239000003212 astringent agent Substances 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 2
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 208000025844 Prostatic disease Diseases 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 210000004404 adrenal cortex Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000013507 chronic prostatitis Diseases 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 1
- IPDWABJNXLNLRA-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IPDWABJNXLNLRA-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 101001011741 Bos taurus Insulin Proteins 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000004211 Flavoxanthin Substances 0.000 description 1
- QHUMOJKEVAPSCY-JOJDNVQPSA-N Flavoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1(C)OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C QHUMOJKEVAPSCY-JOJDNVQPSA-N 0.000 description 1
- JRHJXXLCNATYLS-NGZWBNMCSA-N Flavoxanthin Chemical compound C/C([C@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-NGZWBNMCSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000731961 Juncaceae Species 0.000 description 1
- 244000003187 Juncus effusus Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000034493 Mucous membrane disease Diseases 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000904014 Pappus Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000606596 Pollia <gastropod> Species 0.000 description 1
- 241001396196 Pollia japonica Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000292546 Taraxacum mongolicum Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 1
- 239000004213 Violaxanthin Substances 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019243 flavoxanthin Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000018934 joint symptom Diseases 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000002885 octadecanoids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000019245 violaxanthin Nutrition 0.000 description 1
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Insects & Arthropods (AREA)
- Urology & Nephrology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
本发明公开了一种复方蒲公英花粉通淋膏。它由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为30~50重量份,荷花花粉的用量为10~20重量份,五味子蜂蜜的用量为30~45重量份,蜂王浆的用量为1~5重量份,杜若根的用量为5~15重量份,灯芯草的用量为1~10重量份,生理盐水的用量为5~10重量份。本发明具有可有效防治泌尿系统疾病,缓解患者的痛苦的优点。本发明还公开了制备所述的复方蒲公英花粉通淋膏的方法。
Description
技术领域
本发明涉及保健食品领域,更具体地说它是复方蒲公英花粉通淋膏。本发明还涉及复方蒲公英花粉通淋膏的制备方法。
背景技术
蒲公英(拉丁学名:Taraxacum mongolicum Hand.-Mazz.)菊科,蒲公英属多年生草本植物;根圆锥状,表面棕褐色,皱缩,叶边缘有时具波状齿或羽状深裂,基部渐狭成叶柄,叶柄及主脉常带红紫色,花葶上部紫红色,密被蛛丝状白色长柔毛;头状花序,总苞钟状,瘦果暗褐色,长冠毛白色,花果期4~10月;蒲公英别名黄花地丁、婆婆丁、华花郎等;蒲公英富含维生素A、维生素C及钾,也含有铁、钙、维生素B2、维生素B1、镁、维生素B6、叶酸及铜;蒲公英是菊科多年生草本植物,别名黄花地丁、婆婆丁、华花郎等。广泛生于中、低海拔地区的山坡草地、路边、田野、河滩;蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分。性味甘,微苦,寒。归肝、胃经。有利尿、缓泻、退黄疸、利胆等功效。治热毒、痈肿、疮疡、内痈、目赤肿痛、湿热、黄疸、小便淋沥涩痛、疔疮肿毒,乳痈,瘰疬,牙痛,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛。治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染等;蒲公英全草含蒲公英甾醇、胆碱、菊糖、果胶等;根中含蒲公英醇、蒲公英赛醇、ψ-葡公英甾醇、蒲公英甾醇、β-香树脂醇、豆甾醇、β-谷甾醇、胆碱、有机酸、果糖、蔗糖、葡萄糖、葡萄糖甙以及树脂、橡胶等;叶含叶黄素、蝴蝶梅黄素、叶绿醌、维生素C(50~70毫克/100克)和维生素D(5~9毫克/100克);花中含山金车二醇、叶黄素和毛莨黄素;花粉中含β-谷甾醇、5z-豆甾-7-烯-3β-醇、叶酸和维生素C;绿色花萼中含叶绿醌;花茎中含β-谷甾醇和β-香树脂醇;又该品含考迈斯托醇、核黄素1.43微克/克和胡萝卜素7.7~8.8毫克%;蒲公英治热毒、痈肿、疮疡、内痈、目赤肿痛、湿热、黄疸、小便淋沥涩痛、疔疮肿毒,乳痈,瘰疬,牙痛,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛;蒲公英治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染等;蒲公英可生吃、炒食、做汤,是药食兼用的植物;蒲公英的功能主治:清热解毒,利尿散结。治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染;花粉是有花植物雄性器官,是雄蕊中的生殖细胞,外观呈粉末状,其个体称“花粉粒”;花粉能调节神经系统,促进睡眠,增强体质;改善肠胃功能,促进消化,增强食欲,防治习惯性便秘;保肝护肝,防治贫血、糖尿病、前列腺肥大、心脑血管疾病;调节内分泌,改善机体功能;治疗慢性支气管炎和粘膜症等;尤其值得一提的是,它是既可口服又可外用的美容佳品;蒲公英花粉的作用:有化痰、利尿、补肾、散寒之功效,并能通经活络,提神醒脑,对人体血液再生有一定的辅助作用。
荷花粉是蜜蜂采集荷花之精华;荷花粉在蜂花粉系列中属于名贵产品,不仅具有美容、调养等功效,还是无污染的纯天然产品,在国内外市场很受青睐,只是采集难度比较大,荷花又局限于江南才有,市场上一直比较缺乏;荷花粉主要功能表现为:清心凉血、解热毒、消湿祛风、调内分泌。对雀斑、青春痘、失眠、肠胃等疾病的治疗效果良好,是保健滋补美容营养之最佳品;荷花粉的用途很广泛,也可用来治疗痢疾,肠胃炎,小便不利,水肿肝炎对防止动脉硬化,增强心肌收缩,加快心率改善心肌功能及消减脂肪有特效等;荷花粉主产于江南,江西、湖南、湖北等地,生产季节每年的7-8月份;色泽呈乳黄色,特有荷花清新的香气;产量低、口感好价格较高;荷花粉具有预防和治疗前列腺疾病,清除体内垃圾、治疗便秘和女性更年期综合症,天然美容功效,能促进人体免疫器官发育、具有抗辐射效果;荷花花粉具有养心安神,固精止遗,固精益精,收涩止血,排毒美容,是滋补营养的佳品。
五味子蜜五味子蜜属中药蜜种;采自涩肠止泻的五味子花蜜,色泽略深,味甘甜,略有中药香气;五味子蜜,百妙纷呈,居家常备,定能起到意外之功;该蜜内含五味子素、苹果酸柠檬酸、维生素A和C,故能治神经官能症、干眼病与口腔疾病,并可清肝火,补五脏之气;还具有解毒、止腹泻、杀菌及收敛作用,对肺肾双虚、脾肾虚寒、气促喘乏、痰火郁肺有良好辅疗效果;特别适合虚汗、肺虚、肾虚、久泻久痢、痔血、便血等人日常食疗保健之用;五味子蜂蜜集五味子之精华,功效更胜一筹;五味子蜂蜜具有宁心安神,养阴润肠之功效,可固精强肾、生津润燥,降大热,消炎等作用。
蜂王浆(royal jelly),又名蜂皇浆、蜂皇乳、蜂王乳、蜂乳,是蜜蜂巢中培育幼虫的青年工蜂咽头腺的分泌物,是供给将要变成蜂王的幼虫的食物,也是蜂王终身的食物。蜂王浆含有较多的维生素,尤其是B族维生素特别丰富;蜂王浆另外主要有:硫胺素(B1)、核黄素(B2)、吡哆醇(B6)、维生素B12、烟酸、泛酸、叶酸、生物素、肌醇、维生素C、维生素D等,其中泛酸含量最高;蜂王浆含有26种以上的脂肪酸,已被鉴定的有12种,它们是10-羟基-2-癸烯酸(10-HDA)、癸酸、壬酸、十一烷酸、十二烷酸、十四烷酸(肉豆蔻酸)、肉豆蔻脑酸、十六烷酸(棕榈酸)、十八烷酸、棕榈油酸、花生酸和亚油酸等,其中10-羟基-2-癸烯酸,含量在1.4%以上,由于自然界中只有蜂王浆中含有这种物质,所以也把它称之为王浆酸;蜂王浆的主要作用包括辅助降低血糖,抗氧化功效,降低血脂,控制血管扩张、降低血压,保护肝脏,抗菌、消炎,抗衰老作用,和强化性功能作用,同时还有抗辐射,增强记忆力的作用;营养学家认为,蜂王浆是一种可供人类直接服用的高活性成分的超级营养食品;美、英、法、德、意、日等国医药界人士总结出蜂王浆有以下功效:新鲜的蜂王浆含一定量的乙酰胆碱,能对人体的神经系统起到保健作用;蜂王浆富含维生素B和优质蛋白质,特别是含杀菌力强的皇浆酸,因而为治癌良药;蜂王浆有促进造血功能作用,可增加血红蛋白,促进生长,提高抗病力;蜂王浆内含有泛酸,可改善风湿症和关节症状。蜂王浆含类胰岛素样肽类,其分子量与牛胰岛素相同,对糖尿病患者的胰岛功能有较好调节功能;蜂王浆可强化肾上腺皮质机能,调节人体激素,活化间脑细胞,有利于治疗更年期障碍症和慢性前列腺炎症;蜂王浆能增强人的基础体力,使人体衰老组织活化,服后食欲好,长精神,气色佳;蜂王浆所含肽与蛋白质类保健因子,可促进智力发展,因而服用可提高记忆力;蜂王浆含蛋白质激素和天然抗生素,涂抹治疗烫伤时能起到防止感染、促进细胞生成、愈后不留疤痕的作用;蜂王浆含多种无机盐,能促进肝糖释放,促进代谢,因而可以美容,消除斑纹;蜂王浆具有良好的调节血脂的功效。
杜若,(拉丁文名:Pollia japonica Thunb.),别名:地藕、竹叶莲、山竹壳菜;鸭跖草科、杜若属多年生直立或上升草本,高50-90厘米,有细长的横走根茎;根状茎或全草(竹叶莲):辛,微温;根状茎:补肾;用于腰痛,跌打损伤;全草:理气止痛,疏风消肿;用于气滞作痛,肌肤肿痛,胃痛,淋证;外用于蛇虫咬伤,痈疔疖,脱肛。
灯心草,中药名;为灯心草科植物灯心草Juncus effusus L.的干燥茎髓;夏末至秋季割取茎,晒干,取出茎髓,理直,扎成小把;本品呈细圆柱形,长达2250px,直径0.1~7.5px。表面白色或淡黄白色,有细纵纹;体轻,质软,略有弹性,易拉断,断面白色;气微,味淡;主产于江苏、福建、四川、贵州、云南;入药部位为植物的干燥茎髓;主治用于心烦失眠,尿少涩痛,口舌生疮。
以上物质不但可以平时作为保健品食用,也可以作为药材使用,共同使用或使用时,更能够相互促进;现由于社会的发展、生活节奏变快,很多人都患有泌尿系统疾病,泌尿系统疾病给人的工作、生活带来很大不便,因此,有必要开发一种防治泌尿系统疾病通淋膏,可有效防治泌尿系统疾病,利尿通淋,缓解患者的痛苦。
发明内容
本发明的第一目的是为了提供一种复方蒲公英花粉通淋膏,可有效防治泌尿系统疾病,利尿通淋,缓解患者的痛苦。
本发明的第二目的是为了提供复方蒲公英花粉通淋膏的制备方法。
为了实现上述本发明的第一目的,本发明的技术方案为:复方蒲公英花粉通淋膏,其特征在于:由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为30~50重量份,荷花花粉的用量为10~20重量份,五味子蜂蜜的用量为30~45重量份,蜂王浆的用量为1~5重量份,杜若根的用量为5~15重量份,灯芯草的用量为1~10重量份,生理盐水的用量为5~10重量份;
在上述技术方案中,蒲公英花粉的用量为35~47重量份,荷花花粉的用量为12~18重量份,五味子蜂蜜的用量为33~39重量份,蜂王浆的用量为2~5重量份,杜若根的用量为10~15重量份,灯芯草的用量为4~8重量份,生理盐水的用量为5~9重量份。
在上述技术方案中,蒲公英花粉的用量为41~43重量份,荷花花粉的用量为14~16重量份,五味子蜂蜜的用量为33~35重量份,蜂王浆的用量为2~4重量份,杜若根的用量为11~13重量份,灯芯草的用量为5~7重量份,生理盐水的用量为5~7重量份。
在上述技术方案中,蒲公英花粉、蜂王浆、杜若根、灯芯草的重量比为7:0.5:2:1。
在上述技术方案中,蒲公英花粉的用量为42重量份,荷花花粉的用量为15重量份,五味子蜂蜜的用量为34重量份,蜂王浆的用量为3重量份,杜若根的用量为12量份,灯芯草的用量为6重量份,生理盐水的用量为6重量份。
为了实现上述本发明的第二目的,本发明的技术方案为:制备所述的复方蒲公英花粉通淋膏的方法,其特征在于:它包括如下步骤:
步骤1:将杜若根、灯芯草按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
在上述技术方案中,步骤2中,在摄氏10℃~15℃室温内放置48小时。
在上述技术方案中,在摄氏15℃~18℃室温内连续搅拌26日,每日搅拌2小时。
本发明具有如下优点:
(1)本发明可有效防治泌尿系统疾病,利尿通淋,缓解患者的痛苦;
(2)本发明配比合理,具有很好的营养价值和防治泌尿系统疾病效果,尤其对康复期的泌尿系统疾病患者,具有很好的康复作用;
(3)不添加防腐剂,是一种健康绿色纯天然制品,有益于使用者的身体健康;
(4)蒲公英的功能主治:清热解毒,利尿散结,治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染;荷花粉具有预防和治疗前列腺疾病,清除体内垃圾、治疗便秘和女性更年期综合症,天然美容功效,能促进人体免疫器官发育、具有抗辐射效果;荷花花粉具有养心安神,固精止遗,固精益精,收涩止血,排毒美容,是滋补营养的佳品;蜂王浆可强化肾上腺皮质机能,调节人体激素,活化间脑细胞,有利于治疗更年期障碍症和慢性前列腺炎症;杜若根状茎:补肾;用于腰痛,跌打损伤;全草:理气止痛,疏风消肿;用于气滞作痛,肌肤肿痛,胃痛,淋证;灯心草主治用于心烦失眠,尿少涩痛,口舌生疮;本发明长期使用可增强人体免疫力,因为本发明原料均为天然产品,除花粉过敏体质者外、长期服用并无对人体有任何不良反应;
(5)状态稳定,制备工艺合理,制备温度不高,能有效避免各组分原料失去活性,大大提高制备产品的保健效果。
具体实施方式
下面结合实施例详细说明本发明的实施情况,但它们并不构成对本发明的限定,仅作举例而已。同时通过说明使本发明的优点更加清楚和容易理解。
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为30~50重量份,荷花花粉的用量为10~20重量份,五味子蜂蜜的用量为30~45重量份,蜂王浆的用量为1~5重量份,杜若根的用量为5~15重量份,灯芯草的用量为1~10重量份,生理盐水的用量为5~10重量份;
进一步地,蒲公英花粉的用量为35~47重量份,荷花花粉的用量为12~18重量份,五味子蜂蜜的用量为33~39重量份,蜂王浆的用量为2~5重量份,杜若根的用量为10~15重量份,灯芯草的用量为4~8重量份,生理盐水的用量为5~9重量份。
进一步地,蒲公英花粉的用量为41~43重量份,荷花花粉的用量为14~16重量份,五味子蜂蜜的用量为33~35重量份,蜂王浆的用量为2~4重量份,杜若根的用量为11~13重量份,灯芯草的用量为5~7重量份,生理盐水的用量为5~7重量份。
进一步地,蒲公英花粉、蜂王浆、杜若根、灯芯草的重量比为7:0.5:2:1。
更进一步地,蒲公英花粉的用量为42重量份,荷花花粉的用量为15重量份,五味子蜂蜜的用量为34重量份,蜂王浆的用量为3重量份,杜若根的用量为12量份,灯芯草的用量为6重量份,生理盐水的用量为6重量份。
制备所述的复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:将杜若根、灯芯草按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
进一步地,步骤2中,在摄氏10℃~15℃室温内放置48小时。
更进一步地,在摄氏15℃~18℃室温内连续搅拌26日,每日搅拌2小时。
实施例1
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为30重量份,荷花花粉的用量为20重量份,五味子蜂蜜的用量为45重量份,蜂王浆的用量为1重量份,杜若根的用量为5量份,灯芯草的用量为1重量份,生理盐水的用量为5重量份。
制备复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:将杜若根、灯芯草按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌30日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
实施例2
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为50重量份,荷花花粉的用量为10重量份,五味子蜂蜜的用量为30重量份,蜂王浆的用量为5重量份,杜若根的用量为15量份,灯芯草的用量为8重量份,生理盐水的用量为9重量份。
制备复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:将杜若根、灯芯草按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置50小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
实施例3
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为42重量份,荷花花粉的用量为15重量份,五味子蜂蜜的用量为34重量份,蜂王浆的用量为3重量份,杜若根的用量为12量份,灯芯草的用量为6重量份,生理盐水的用量为6重量份。
制备复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:将杜若根、灯芯草按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
实施例4
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为47重量份,荷花花粉的用量为12重量份,五味子蜂蜜的用量为39重量份,蜂王浆的用量为2重量份,杜若根的用量为10量份,灯芯草的用量10重量份,生理盐水的用量为7重量份。
其制备方法同实施例1。
实施例5
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为41重量份,荷花花粉的用量为18重量份,五味子蜂蜜的用量为33重量份,蜂王浆的用量为5重量份,杜若根的用量为11量份,灯芯草的用量为4重量份,生理盐水的用量为10重量份。
其制备方法同实施例3。
实施例6
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为43重量份,荷花花粉的用量为14重量份,五味子蜂蜜的用量为35重量份,蜂王浆的用量为4重量份,杜若根的用量为13量份,灯芯草的用量为7重量份,生理盐水的用量为8重量份。
其制备方法同实施例3。
实施例7
复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为35重量份,荷花花粉的用量为16重量份,五味子蜂蜜的用量为34重量份,蜂王浆的用量为3重量份,杜若根的用量为10量份,灯芯草的用量为5重量份,生理盐水的用量为7重量份。
其制备方法同实施例2。
对比例1
对比复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为20重量份,荷花花粉的用量为8重量份,五味子蜂蜜的用量为55重量份,蜂王浆的用量为0.1重量份,杜若根的用量为20量份,灯芯草的用量为15重量份,生理盐水的用量为15重量份。
其制备方法同实施例3。
对比例2
对比复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、生理盐水组成;蒲公英花粉的用量为15重量份,荷花花粉的用量为38重量份,五味子蜂蜜的用量为50重量份,生理盐水的用量为20重量份。
制备复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:按重量份将磨碎的荷花花粉、生理盐水混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤2:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤3:将步骤3所得的混合原料置于60目的加压过滤器中过滤即得成品。
对比例3
对比复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、生理盐水组成;蒲公英花粉的用量为20重量份,荷花花粉的用量为8重量份,五味子蜂蜜的用量为55重量份,蜂王浆的用量为1重量份,杜若根的用量为20量份,生理盐水的用量为15重量份。
制备复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:将杜若根按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
对比例4
对比复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、灯芯草、生理盐水组成;蒲公英花粉的用量为20重量份,荷花花粉的用量为8重量份,五味子蜂蜜的用量为55重量份,蜂王浆的用量为1重量份,灯芯草的用量为15重量份,生理盐水的用量为15重量份。
制备复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:将灯芯草按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
对比例5
对比复方蒲公英花粉通淋膏,由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、生理盐水组成;蒲公英花粉的用量为20重量份,荷花花粉的用量为8重量份,五味子蜂蜜的用量为55重量份,蜂王浆的用量为1重量份,杜若根的用量为20量份,灯芯草的用量为15重量份,生理盐水的用量为15重量份。
制备复方蒲公英花粉通淋膏的方法,它包括如下步骤:
步骤1:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤2:将重量份的五味子蜂蜜加入步骤1所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤3:将蜂王浆加入步骤2的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤4:将步骤3所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
对1000名泌尿系统疾病康复期患者试验,其中男573人,女427人,年龄最大62岁,最小21岁,随机分为十组,每组100人;服用期间不可饮酒,不能吃辛辣食物,不能吃将腌制品、豆制品、咖啡、刺激性强的食物;必须以清淡为主。
空白对照为不服用复方蒲公英花粉通淋膏相关产品,其他分别为每天早晚各服用一勺复方蒲公英花粉通淋膏,服用2个月;所得结果如下:
表1 实施例及对比例效果
泌尿系统疾病复发比例(%) | 评价 | |
实施例1 | 11.3 | 利尿通淋效果好 |
实施例2 | 8.9 | 利尿通淋效果较好 |
实施例3 | 7.8 | 利尿通淋效果较好 |
实施例4 | 16.3 | 利尿通淋效果好 |
实施例5 | 14.6 | 利尿通淋效果好 |
实施例6 | 8.1 | 利尿通淋效果较好 |
实施例7 | 15.7 | 利尿通淋效果好 |
对比例1 | 26.2 | 利尿通淋效果一般 |
对比例2 | 36.5 | 利尿通淋效果一般 |
对比例3 | 24.1 | 利尿通淋效果一般 |
对比例4 | 26.3 | 利尿通淋效果一般 |
对比例5 | 29.7 | 利尿通淋效果一般 |
空白对照 | 50 | - |
上表中,泌尿系统疾病复发比例为10一下视为利尿通淋效果良好,泌尿系统疾病复发比例为10%~20%视为利尿通淋效果好,泌尿系统疾病复发比例低于40%视为利尿通淋效果一般。从上表可以看出,添加含有杜若根或灯芯草的复方蒲公英花粉通淋膏的利尿通淋效果好于不添加杜若根和灯芯草的复方蒲公英花粉通淋膏,添加含有杜若根的复方蒲公英花粉通淋膏的利尿通淋效果好于添加灯芯草的复方蒲公英花粉通淋膏,添加杜若根和灯芯草的复方蒲公英花粉通淋膏的利尿通淋效果好于不添加蒲公英花粉、蜂王浆、杜若根、灯芯草的复方蒲公英花粉通淋膏,添加含有蒲公英花粉、蜂王浆、杜若根、灯芯草的复方蒲公英花粉通淋膏具有更好的利尿通淋效果,并且蒲公英花粉、蜂王浆、杜若根、灯芯草的重量比为7:0.5:2:1时,制得的复方蒲公英花粉通淋膏利尿通淋效果最好。
其它未说明的部分均属于现有技术。
Claims (8)
1.复方蒲公英花粉通淋膏,其特征在于:由蒲公英花粉、荷花花粉、五味子蜂蜜、蜂王浆、杜若根、灯芯草、生理盐水组成;蒲公英花粉的用量为30~50重量份,荷花花粉的用量为10~20重量份,五味子蜂蜜的用量为30~45重量份,蜂王浆的用量为1~5重量份,杜若根的用量为5~15重量份,灯芯草的用量为1~10重量份,生理盐水的用量为5~10重量份。
2.根据权利要求1所述的复方蒲公英花粉通淋膏,其特征在于:蒲公英花粉的用量为35~47重量份,荷花花粉的用量为12~18重量份,五味子蜂蜜的用量为33~39重量份,蜂王浆的用量为2~5重量份,杜若根的用量为10~15重量份,灯芯草的用量为4~8重量份,生理盐水的用量为5~9重量份。
3.根据权利要求2所述的复方蒲公英花粉通淋膏,其特征在于:蒲公英花粉的用量为41~43重量份,荷花花粉的用量为14~16重量份,五味子蜂蜜的用量为33~35重量份,蜂王浆的用量为2~4重量份,杜若根的用量为11~13重量份,灯芯草的用量为5~7重量份,生理盐水的用量为5~7重量份。
4.根据权利要求3所述的复方蒲公英花粉通淋膏,其特征在于:蒲公英花粉、蜂王浆、杜若根、灯芯草的重量比为7:0.5:2:1。
5.根据权利要求4所述的复方蒲公英花粉通淋膏,其特征在于:蒲公英花粉的用量为42重量份,荷花花粉的用量为15重量份,五味子蜂蜜的用量为34重量份,蜂王浆的用量为3重量份,杜若根的用量为12量份,灯芯草的用量为6重量份,生理盐水的用量为6重量份。
6.制备上述权利要求1至5中任一项权利要求所述的复方蒲公英花粉通淋膏的方法,其特征在于:它包括如下步骤:
步骤1:将杜若根、灯芯草按重量比加蒸馏水在铁锅中加热煮沸熬制五小时成糊状物,去渣,烘干成结晶体,冷却,得到复配晶体;
步骤2:按重量份将磨碎的蒲公英花粉、荷花花粉、生理盐水与步骤1所得的复配晶体混合均匀,置于已消毒的容器内,在摄氏10℃~15℃室温内放置30~50小时,得到混合原料;
步骤3:将重量份的五味子蜂蜜加入步骤2所得的混合原料,混合均匀,在摄氏15℃~18℃室温内连续搅拌20~30日,每日搅拌2小时;
步骤4:将蜂王浆加入步骤3的混合物中,在摄氏5℃室温内连续搅拌至均匀;
步骤5:将步骤4所得的含有蜂王浆的混合原料置于60目的加压过滤器中过滤即得成品。
7.根据权利要求6所述的制备所述的复方蒲公英花粉通淋膏的方法,其特征在于:步骤2中,在摄氏10℃~15℃室温内放置48小时。
8.根据权利要求7所述的制备所述的复方蒲公英花粉通淋膏的方法,其特征在于:在摄氏15℃~18℃室温内连续搅拌26日,每日搅拌2小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810910143.4A CN109329935A (zh) | 2018-08-10 | 2018-08-10 | 复方蒲公英花粉通淋膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810910143.4A CN109329935A (zh) | 2018-08-10 | 2018-08-10 | 复方蒲公英花粉通淋膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109329935A true CN109329935A (zh) | 2019-02-15 |
Family
ID=65291436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810910143.4A Pending CN109329935A (zh) | 2018-08-10 | 2018-08-10 | 复方蒲公英花粉通淋膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109329935A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1631217A (zh) * | 2004-11-29 | 2005-06-29 | 沈道金 | 刺五加、王浆、花粉、蜜浓缩液及其制备方法 |
CN101361535A (zh) * | 2008-09-24 | 2009-02-11 | 何德枫 | 复方花粉膏及其制备方法 |
CN105476000A (zh) * | 2015-11-29 | 2016-04-13 | 武汉乐神三宝蜂业有限公司 | 复方水飞蓟丸剂及其制备方法 |
-
2018
- 2018-08-10 CN CN201810910143.4A patent/CN109329935A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1631217A (zh) * | 2004-11-29 | 2005-06-29 | 沈道金 | 刺五加、王浆、花粉、蜜浓缩液及其制备方法 |
CN101361535A (zh) * | 2008-09-24 | 2009-02-11 | 何德枫 | 复方花粉膏及其制备方法 |
CN105476000A (zh) * | 2015-11-29 | 2016-04-13 | 武汉乐神三宝蜂业有限公司 | 复方水飞蓟丸剂及其制备方法 |
Non-Patent Citations (3)
Title |
---|
刘永新等: "《图解本草纲目》", 31 August 2017 * |
刘珂等: "《养生一点通丛书 小食品大健康》", 31 August 2011 * |
刘进祖等: "《健康长寿因子 蜂产品消费600问》", 30 September 2012 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103340334B (zh) | 一种淡水鱼饲料及其制备方法 | |
CN102450517B (zh) | 一种肉鸡饲料及其使用的中药添加剂 | |
CN103859215A (zh) | 一种蛋鸡产蛋期饲料及其制备方法 | |
CN108185049A (zh) | 一种小青柑养生健胃茶及其制备方法 | |
CN103859379A (zh) | 一种有助于改善记忆的养生保健食品配方及其制备方法 | |
CN102940153A (zh) | 一种改善肉质、蛋质的家禽饲料 | |
CN103749821B (zh) | 一种提高免疫力的绞股蓝保健茶及其制备方法 | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
CN102940219B (zh) | 一种土豆饼及其制作方法 | |
CN104946488B (zh) | 养生龟酒及其制备方法 | |
CN103875973A (zh) | 一种蛋鸡产蛋期饲料添加剂及其制备方法 | |
CN103749824A (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN109699890A (zh) | 一种能缓解痛风和高尿酸的草本植物制剂 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN106070783A (zh) | 一种薏米祛湿茶的生产工艺 | |
CN106509209A (zh) | 一种蜂胶保健茶及其制备方法 | |
CN102823700A (zh) | 一种复方茯苓黑大蒜夹心巧克力的制备方法 | |
CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
CN103960415A (zh) | 一种减肥保健凉茶及其制备方法 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
KR100815333B1 (ko) | 한약재를 이용한 건강식품 및 그 제조방법 | |
CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
CN109329935A (zh) | 复方蒲公英花粉通淋膏及其制备方法 | |
CN104255922A (zh) | 适宜三高人群饮用的保健牛奶及其制备方法 | |
CN107854592A (zh) | 一种可快速消除疼痛感的口腔溃疡贴膜的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190215 |
|
RJ01 | Rejection of invention patent application after publication |